drugset / Trial / NCT01571167

Varenicline as a Treatment for Methamphetamine Dependence

NCT01571167

RandomizedCrossoverQuadruple-blind

Summary

The primary purpose of the study is to determine the effects of treatment with varenicline (1 and 2 mg daily), compared to treatment with placebo, on methamphetamine-induced craving and subjective effects in methamphetamine-dependent human volunteers.

Timeline

Start
2011-01
Primary completion
2012-02
Completion
2012-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Varenicline Small molecule 1 mg Oral
Comparator Varenicline Small molecule 2 mg Oral